In Silico Pharmacology for Evidence-Based and Precision Medicine

Pharmaceutics. 2023 Mar 22;15(3):1014. doi: 10.3390/pharmaceutics15031014.

Abstract

Personalized/precision medicine (PM) originates from the application of molecular pharmacology in clinical practice, representing a new era in healthcare that aims to identify and predict optimum treatment outcomes for a patient or a cohort with similar genotype/phenotype characteristics [...].

Publication types

  • Editorial